CVM-1118: An oral anti-vasculogenic mimicry (VM) agent in combination with nivolumab in patients with unresectable advanced hepatocellular carcinoma (HCC)—A phase IIa study.
| Autor: | Yen, Chia Jui, Huang, Yi-Hsiang, Yeh, Kun-Yun, Chen, Pei-Jer, Lu, Sheng-Nan, Gutheil, John, Melink, Teresa J., Chen, Yen-Ling, Chen, Chun-Man, Chao, Ting-Yu, Chu, Yi-Wen, Chien, Du-Shieng |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement, Vol. 42, p92-92, 48p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|